Manufacturing Next-Gen Therapies: The Vanrx SA25 Aseptic Filling Workcell
Hear from Emergent technical experts and Vanrx (now part of Cytiva) representatives as they discuss the unique features of the Vanrx SA25 and the benefits of utilizing closed, robotic technologies to enhance aseptic filling operations.
This presentation will include:
- A brief introduction and history of Emergent's Winnipeg, Manitoba, Canada manufacturing facility
- An overview of the Vanrx SA25 Aseptic Filling Workcell design features and benefits
- Q&A session with Emergent's Winnipeg drug product manufacturing team and Vanrx representatives
Originally presented on June 23, 2021